Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Keraflox

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

A drug brand. The brand makes an oral antibiotic containing the active pharmaceutical ingredient Prulifloxacin which is used for the treatment of urinary tract infections and chronic bronchitis.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Pharmaceuticals and Biotechnology
Primary Office
  • Milan
  • Italy

Keraflox Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Keraflox‘s full profile, request access.

Request full access to PitchBook

Keraflox Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Keraflox‘s full profile, request access.

Request full access to PitchBook